SYX-5219 Oral Capsule clinical trials

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

This study is testing a new oral medication, SYX-5219, for moderate to severe eczema (atopic dermatitis). It aims to check the drug's safety, how well it's tolerated, and how it moves through the body in both healthy people and those with eczema.